Search Tag: atrial fibrillation
2023 06 Sep
Atrial fibrillation (AF) is a common cardiac arrhythmia. Research has consistently shown that AF heightens the risk of adverse outcomes in hospitalised and outpatient populations. Data suggests that newly developed AF (NAF) is common among critically ill patients, negatively impacting both short- and long-term outcomes, including prolonged hospitalisation...Read more
2022 14 Oct
An overview of the clinical evidence demonstrating the effectiveness of landiolol for the treatment of atrial fibrillation or atrial flutter with heart failure and effective heart rate control during arrhythmias. Supraventricular arrhythmias (SVTs) are common in post-operative and cardiac ICUs. SVTs increase the risk of death...Read more
2021 22 Feb
The 2020 ESC Guidelines and the addition of Landiolol An overview of the updated guidelines for the diagnosis and management of atrial fibrillation, developed in association with the European Association for Cardio-Thoracic Surgery. T he European Society of Cardiology (ESC) provides a range of scientific and educational activities,...Read more
2020 30 Nov
The European Society of Cardiology ( ESC ) has published their new guidelines for the diagnosis and treatment of atrial fibrillation during its congress this year*. The recently released guidelines replace the recommendations of the Society, which were published in 2016. One of the most interesting innovations is the approach towards characterization...Read more
2020 08 Oct
Almost half of the patients with sepsis suffer from myocardial depression and a reduced ejection fraction. Sepsis can also cause changes in circulating volume, vascular tone, and coronary blood flow, all of which affect heart function and heart rate. Serum catecholamine levels and direct measurements of renal sympathetic nerve activity have shown...Read more
2020 23 Apr
Atrial fibrillation (AF) is the most common heartbeat irregularity and associated with development of stroke, myocardial infarction and heart failure. Vice versa, the structural and neurohormonal changes in heart failure (HF), when the contractility of the heart muscle is reduced, make the development and progression of AF much more likely. HF itself...Read more
2018 24 Apr
Atrial fibrillation (AF) is the most common arrhythmia encountered in the intensive care unit. Pre-existing AF is highly prevalent among older patients with chronic conditions who are at risk for critical illness, while new-onset AF can be triggered by accelerated atrial remodelling and arrhythmogenic triggers encountered during critical illness. However,...Read more
2018 03 Apr
A new study compared outcomes among patients with atrial fibrillation hospitalised for bleeding after starting anticoagulation (warfarin, dabigatran, or rivaroxaban). Results show rivaroxaban and dabigatran were associated with shorter hospitalisations; however, there were no differences in 30- and 90-day mortality. These findings suggest bleeding...Read more
2015 25 Apr
A new study shows that new-onset atrial fibrillation (AF), a common arrhythmia in the ICU, occurred in approximately 5 to 15 percent of all non-cardiac critically ill patients — a figure exceeding previous estimates. Also, hospital mortality in new-onset AF patients was higher than that of patients without AF, according to the study published in the...Read more
2014 12 Mar
As the first hospital in Illinois, the Loyola University Medical Center offers a new high-tech catheter device able to improve outcomes of patients treated for atrial fibrillation, the most common irregular heartbeat. The treatment, entitled catheter ablation, involves burning selected spots of tissue inside the heart with the tip of a catheter,...Read more